| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Tango Therapeutics, Inc.
13D/A
TNGX · 87583X109
|
10.0% |
1/2/2025
Event 12/30/2024
|
||||
| BCTG Holdings, LLC | 0% | |||||
| MVA Investors, LLC | 0.3% | |||||
| Davis Aaron I. | 10.0% | |||||
| Boxer Capital Management, LLC | 9.7% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.